User's Manual

Table Of Contents
www.spacelabshealthcare.com
1-5
TELEMETRY TRANSMITTER (96281)
I
NTRODUCTION
Medical telemetry spectrum allocations may be assigned
to frequencies already allotted to other priority users.
Radio frequency interference from other products may
disrupt or impede telemetry patient monitoring during the
life of this equipment. You are urged to regularly consult
with applicable local and federal regulatory agencies
(e.g., FCC, FDA) regarding the locations and frequencies
of other spectrum users in your geographic area. A
Spacelabs Healthcare field service engineer may be able
to assist you in reconfiguring your equipment frequencies
to reduce the risk of interference. Spacelabs Healthcare
cannot, and does not, guarantee interference-free
telemetry operation.
Telemetry systems may be more susceptible to
interference than hardwired systems; this may impact
signal quality.
Do not use any transmitter that has been compromised by
liquid ingress. If fluid has collected in the battery
compartment, clean and dry it before use. If the
transmitter has been immersed in liquid, it must be
thoroughly dried before use. Not doing so may prevent
the transmitter from working properly. If the SpO
2
sensor
has been immersed in liquid, it should be dried and
inspected for proper operation and replaced if necessary.
The transmitters do not currently support inhibition of
their pacer detection functionality. Since Left Ventricular
Assist Devices (LVADs) can generate electromagnetic
noise having similar characteristics to pacemaker artifact,
users should pay particular attention to ECG traces
acquired using these transmitters when an LVAD is in use.
Do not use the 96281 telemetry transmitter during
magnetic resonance imaging (MRI) procedures. MRI
operations will cause damage to the transmitter.
Remove the 96281 telemetry transmitter from any patient
before beginning an MRI procedure.
Operation of hand-held, wireless telephone equipment
(cordless telephones, cellular telephones) near telemetry
systems may cause interference and should be
discouraged. While personal communication devices are
turned on, a separation of >2 meters (>6.5 feet) should be
maintained between personal communication devices and
interior walls, the patient cables, and any electronic
medical device to which the patient may be connected.
Patients should not use any type of electronic
communication equipment while connected to any
electronic medical device without an on-site evaluation by
the biomedical staff. Two-way radio equipment and other
personal communication devices must be evaluated on
site to determine if additional space limitations are
needed.